Skip to content
10-Q

Quarterly Report

Dthera Sciences

0001683168-18-001373

← back to feed
Filed
May 15, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 15, 2018 50.34M sh
Operating Cash Flow Q1 2018 · Mar 31, 2018 −$824.74K
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$200.85K
Cash And Equivalents Q1 2018 · Mar 31, 2018 $428.97K
Cash And Equivalents Q1 2018 · Dec 31, 2017 $323.48K
Cash And Equivalents Q1 2018 · Mar 31, 2017 $467.34K
Cash And Equivalents Q1 2018 · Dec 31, 2016 $12.19K
Stockholders Equity Q1 2018 · Mar 31, 2018 $550.05K
Stockholders Equity Q1 2018 · Dec 31, 2017 $60.25K
Current Liabilities Q1 2018 · Mar 31, 2018 $331.14K
Current Liabilities Q1 2018 · Dec 31, 2017 $438.27K
Total Liabilities Q1 2018 · Mar 31, 2018 $331.14K
Total Liabilities Q1 2018 · Dec 31, 2017 $438.27K
Current Assets Q1 2018 · Mar 31, 2018 $709.34K
Current Assets Q1 2018 · Dec 31, 2017 $421.16K
Total Assets Q1 2018 · Mar 31, 2018 $881.19K
Total Assets Q1 2018 · Dec 31, 2017 $498.52K
Sga Expense Q1 2018 · Mar 31, 2018 $597.07K
Sga Expense restated Q1 2018 · Mar 31, 2017 $345.5K
Rd Expense Q1 2018 · Mar 31, 2018 $10.41K
Rd Expense Q1 2018 · Mar 31, 2017 $6.97K
Net Income Q1 2018 · Mar 31, 2018 −$610.54K
Net Income Q1 2018 · Mar 31, 2017 −$487.08K
Operating Income Q1 2018 · Mar 31, 2018 −$607.48K
Operating Income Q1 2018 · Mar 31, 2017 −$352.47K
Revenue Q1 2018 · Mar 31, 2018 $0
Revenue Q1 2018 · Mar 31, 2017 $0